Lactosaminated human serum albumin as hepatotropic drug carrier
- 6 September 1982
- journal article
- Published by Wiley in FEBS Letters
- Vol. 146 (1), 42-46
- https://doi.org/10.1016/0014-5793(82)80701-1
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Hepatocyte targeting of adenine‐9‐β‐D‐arabinofuranoside 5′‐monophosphate (ara‐AMP) coupled to lactosaminated albuminFEBS Letters, 1981
- Antiviral Treatment of Chronic Hepatitis B Virus Infection. I. Changes in Viral Markers with Interferon Combined with Adenine ArabinosideThe Journal of Infectious Diseases, 1981
- VidarabineDrugs, 1980
- Selective inhibition of ectromelia virus DNA synthesis in hepatocytes by adenine‐9‐β‐D‐arabinofuranoside (ara‐A) and adenine‐9‐β‐D‐arabinofuranoside 5′‐monophosphate (ara‐AMP) conjugated to asialofetuinFEBS Letters, 1980
- An electron microscope autoradiographic study of the carbohydrate recognition systems in rat liver. II. Intracellular fates of the 125I-ligands.The Journal of cell biology, 1979
- An electron microscope autoradiographic study of the carbohydrate recognition systems in rat liver. I. Distribution of 125I-ligands among the liver cell types.The Journal of cell biology, 1979
- Enhanced inhibition of virus DNA synthesis in hepatocytes by trifluorothymidine coupled to asialofetuinFEBS Letters, 1979
- HBsAg-positive chronic liver disease: inhibition of DNA polymerase activity by vidarabine.BMJ, 1978
- Elimination of asialofetuin and asialoorosomucoid by the intact rat quantitative aspects of the hepatic clearance mechanismBiochimica et Biophysica Acta (BBA) - General Subjects, 1978
- Attachment of thioglycosides to proteins: enhancement of liver membrane bindingBiochemistry, 1976